Accretive Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$596K Buy
4,952
+308
+7% +$35.6K 0.17% 111
2025
Q4
$489K Sell
4,644
-545
-11% -$51.2K 0.15% 109
2025
Q3
$436K Hold
5,189
0.13% 113
2025
Q2
$411K Sell
5,189
-100
-2% -$7.95K 0.13% 114
2025
Q1
$418K Sell
5,289
-53
-1% -$4.95K 0.15% 112
2024
Q4
$531K Buy
+5,342
New +$551K 0.23% 100

Other funds holding MRK

Accretive Wealth Partners's MRK Position: Q1 2026 in Review

Accretive Wealth Partners increased its Merck (MRK) stake by 6.6% in Q1 2026, buying an estimated $35.6K and bringing the position to 4,952 shares worth $596K. The position accounts for 0.17% of the portfolio, ranked #111.

Accretive Wealth Partners first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Accretive Wealth Partners held 4,952 shares of Merck worth $596K as of Q1 2026.
  • Accretive Wealth Partners bought 308 Merck shares in Q1 2026, an estimated $35.6K.
  • Merck made up 0.17% of Accretive Wealth Partners's portfolio in Q1 2026, its #111 holding.
  • Accretive Wealth Partners first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Accretive Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.